Contribution of β-lactamases to β-lactam susceptibilities of susceptible and multidrug-resistant Mycobacterium tuberculosis clinical isolates

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 6, 1998, Pages 1524-1526

  Segura, C ^a,c   Salvado M ^a   Collado, I ^b   Chaves, J ^b   Coira, A ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM; BETA LACTAMASE; CARBENICILLIN; CEFOTAXIME; CEFTRIAXONE; CIPROFLOXACIN; CLAVULANIC ACID; ISONIAZID; OFLOXACIN; RIFAMPICIN; STREPTOMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATION; DRUG SENSITIVITY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS;

EID: 0031805508     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.6.1524     Document Type: Article

References (25)

1. Amicosante, G., N. Franceschini, B. Segatore, A. Oratore, et al. 1990. Characterization of a betalactamase produced in Mycobacterium fortuitum D316. Biochem. J. 271:729-734.
2. Bloom, B. R., and C. J. C. Murray. 1992. Tuberculosis: commentary on a reemergent killer. Science 257:1055-1064.
3. Brudney, K., and J. Dobkin. 1992. Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am. Rev. Respir. Dis. 144:745-744.
4. Bush, K., and R. B. Sykes. 1984. Beta-lactamase (penicillinase, cephalosporinase), p. 280-284. In H. U. Bergmeyer (ed.), Methods of enzymatic analysis, 3rd ed., vol. 4. Verlag Chemie, Weinheim, Germany.
5. Bush, K., and R. B. Sykes. 1986. Methodology for the study of β-lactamases. Antimicrob. Agents Chemother. 30:6-10.
6. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
7. Casal, M., F. Rodríguez, and M. Benavente. 1986. In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium fortuitum and Mycobacterium chelonei to amoxicillin/clavulanic acid. Eur. J. Clin. Microbiol. 5:453-454.
8. Casal, M. J., F. C. Rodriguez, M. D. Luna, and M. C. Benavente. 1987. In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis, Mycobacterium fortuitum, and Mycobacterium chelonae to ticarcillin in combination with clavulanic acid. Antimicrob. Agents Chemother. 31:132-133.
9. Chambers, H. F., D. Moreau, D. Yajko, C. Miick, C. Wagner, C. Hackbarth, S. Kocagöz, E. Rosenberg, W. K. Hadley, and H. Nikaido. 1995. Can penicillins and other β-lactam antibiotics be used to treat tuberculosis? Antimicrob. Agents Chemother. 39:2620-2624.
10. Cynamon, M. H., and G. S. Palmer. 1983. In vitro activity of amoxicillin in combination with clavulanic acid against Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 24:429-131.
11. Eisenach, K. D., J. T. Crawford, and J. H. Bates. 1986. Genetic relatedness among strains of Mycobacterium tuberculosis complex. Am. Rev. Respir. Dis. 133:1065-1068.
12. Ellner, P. D., T. E. Kiehn, R. Camarata, and M. Hosmer. 1988. Rapid detection and identification of pathogenic mycobacteria by combining radiometric and nucleic acid probe methods. J. Clin. Microbiol. 23:1349-1352.
13. Evans, K. D., A. S. Nakasone, P. A. Sutherland, L. M. de la Maza, and E. M. Peterson. 1992. Identification of Mycobacterium tuberculosis and Mycobacterium avium-M. intracellulare directly from primary BACTEC cultures by using acridinum-ester-labeled DNA probes. J. Clin. Microbiol. 30:2427-2431.
14. Hackbarth, C. J., I. Unsal, and H. F. Chambers. 1997. Cloning and sequence analysis of a class A β-lactamase from Mycobacterium tuberculosis H37Ra. Antimicrob. Agents Chemother. 41:1182-1185.
15. Jones, W. D., R. C. Good, N. J. Thompson, and G. D. Kely. 1982. Bacteriophage types of Mycobacterium tuberculosis in the United States. Am. Rev. Respir. Dis. 125:640-643.
16. Kwon, H. H., H. Tomioka, and H. Saito. 1995. Distribution and characterization of betalactamases of mycobacteria and related organisms. Tubercle Lung Dis. 76:141-148.
17. Matthew, M., A. M. Harris, M. J. Marshall, and G. W. Ross. 1975. The use of analytical isoelectric focusing for detection and identification of betalactamases. J. Gen. Microbiol. 88:164-178.
18. Nadler, J. P., J. Berger, J. A. Nord, R. Cofsky, and M. Saxena. 1991. Amoxicillin clavulanic acid for treating drug resistant Mycobacterium tuberculosis. Chest 99:1025-1026.
19. Román, M. C., and L. M. J. Sicilia. 1984. Preliminary investigation of Mycobacterium tuberculosis biovars. J. Clin. Microbiol. 20:1015-1016.
20. Roy, C., C. Segura, M. Tirado, and R. Reig. 1984. Determinación orientativa del espectro de hidrólisis de las betalactamasas de enterobacteriáceas y de Pseudomonas aeruginosa. Rev. Diagn. Biol. 33:27-32.
21. Sorg, T. B., and M. H. Cynamon. 1987. Comparison of four betalactamase inhibitors in combination with ampicillin against Mycobacterium tuberculosis. J. Antimicrob. Chemother. 19:59-64.
22. Vu, H., and H. Nikaido. 1885. Role of β-lactam hydrolysis in the mechanism of resistance of a β-lactamase-constitutive Enterobacter cloacae strain to expanded-spectrum β-lactams. Antimicrob. Agents Chemother. 27:393-398.
23. Wayne, L. G., and G. P. Kubica. 1986. Family Mycobacteriaceae, p. 1436-1457. In P. H. A. Sneath, N. S. Mair, M. E., Sharpe, and J. G. Holt (ed.), Bergey's manual of systematic bacteriology, vol. 2. Williams and Wilkins, Baltimore, Md.
24. Wong, C., M. Cynamon, and J. Gavalchin. 1989. Characterization of the β-lactamase of Mycobacterium tuberculosis, abstr. U-85, p. 169. In Abstracts of the 89th Annual Meeting of the American Society for Microbiology 1989. American Society for Microbiology, Washington, D.C.
25. Zhang, Y., V. Steingrube, and R. J. Wallace. 1442. Betalactamase inhibitors and the inducibility of the betalactamase of Mycobacterium tuberculosis. Am. Rev. Respir. Dis. 145:657-660.